Depressive symptomatology during clozapine treatment: Two case reports

European Neuropsychopharmacology

Volumn 8, Issue 3, 1998, Pages 239-240

  Altamura, A Carlo ^a   Bignotti, Stefano ^b   Tura, Giuseppe ^b   Riccardo Curreli, ^a   Pioli, Rosaria ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Inst for Psychiat Rehab S C   (Italy)

Author keywords

Clozapine; Depression; Paroxetine; Schizophrenia; Serotonergic drugs

Indexed keywords

CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PAROXETINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; CLOMIPRAMINE; CLOZAPINE; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; SCHIZOPHRENIA;

EID: 0032145393     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00082-5     Document Type: Article

References (4)

1. Altamura, A.C., Mauri, M.C., Leva, P., 1991. Depressive symptoms in chronic schizophrenia: clinical and pharmacological variables. In: Racagni, G., et al. (Eds.), Biological Psychiatry, vol. 1. Elsevier Science, Amsterdam, pp. 328-331.
2. Meltzer H.Y., Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am. J. Psychiatry. 152:1995;183-190.
3. Ranjan R., Meltzer H.Y. Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol. Psychiatry. 40:1996;253-258.
4. van Praag, H.M., Asnis, G.M., Brown, S.L., et al., 1991. Beyond serotonin. A multiaminergic perspective on abnormal behavior. In: Brown, S.L., et al. (Eds.), The Role of Serotonin in Psychiatric Disorders. Brunner and Mazel, New York, pp. 302-332.